Sign in Subscribe
Communicable diseases

Graft-Versus-Host Disease Triggers Acute Hepatitis After Stem Cell Transfer

Strategic Insights

— 1 min read

Researchers in South Korea have identified a new syndrome of chronic graft-versus-host disease (GVHD) of the liver, characterized by acute hepatitis, in patients who have undergone nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT). The study, published in the International Journal of Hematology, reveals that three patients developed marked elevations of serum aminotransferases, clinically resembling acute viral hepatitis. Liver biopsies revealed diffuse lobular injury and degenerative small bile ducts, which improved rapidly with high-dose immunosuppressive therapy.

Key Takeaways:

  • Researchers identified a new syndrome of chronic GVHD of the liver, characterized by acute hepatitis, in patients who underwent nonmyeloablative allogeneic HSCT.
  • The syndrome presented with marked elevations of serum aminotransferases, clinically resembling acute viral hepatitis.
  • Liver biopsies revealed diffuse lobular injury and degenerative small bile ducts.
  • High-dose immunosuppressive therapy was effective in rapidly improving liver enzymes and bilirubin levels.
  • The study's findings suggest that chronic hepatic GVHD presenting as an acute hepatitis should be considered a possible explanation for hepatic dysfunction in patients who receive nonmyeloablative allogeneic HSCT.
  • Researchers, including H. Maeng and Y.H. Min from Yonsei University, College of Medicine, emphasized the importance of prompt administration of immunosuppressive therapy in managing this condition.
  • The International Journal of Hematology published the study, which highlights the need for continued research into the complexities of GVHD and its impact on patients undergoing HSCT.

Statistics:

  • 3 patients developed acute hepatitis after undergoing nonmyeloablative allogeneic HSCT.
  • Serum aminotransferases levels were markedly elevated in these patients.
  • Liver biopsies revealed diffuse lobular injury in 100% of patients.
  • Small bile ducts were degenerative in 100% of patients.
  • High-dose immunosuppressive therapy achieved a rapid improvement of liver enzymes and bilirubin levels in 100% of patients.

Sources:

  • International Journal of Hematology (Chronic graft-versus-host disease of the liver presenting as an acute hepatitis following nonmyeloablative hematopoietic stem cell transplantation. Int J Hematol, 2004;79(5):501-504).
  • Y.H. Min, Yonsei University, College Med, Department Internal Medicine, Seoul 120752, South Korea.

Read more